(02) 9926 4726

News and Event

Sydney Vital Seed Funding – Closed

Sydney Vital is pleased to invite applications for its Seed Funding Awards to the value of $25,000 each. The Sydney Vital Seed Funding Scheme intends to seed new ideas, with the goal of generating data to a point where external funding may be sought. The ideas to be tested should be (i) new in concept and (ii) distinct from currently or previously funded research. Projects should focus on Translational Cancer Research and closely align with one or more of Sydney Vital’s Flagship Programs and/or Translational Cancer Research Centres (TCE) which are;

Flagships

Inflammation
Translational Theranostics
Nanotechnology

TCEs

Pancreatic Cancer
Thyroid Cancer
Breast Cancer Implementation
Neuroendocrine Tumours
Glioblastoma
Sydney 1000 CRC
Adrenocortical Cancer

 

Key Dates

Call for Applications: 14 February 2018

Closing Date for Applications: 9th March 2018

 

Useful Documents:

Sydney Vital_Seed Funding Award_Guidelines_Feb 2018

SV_Seed Funding_Application Form_Feb 2018

Any queries should be directed to [email protected]

Read more

Sydney Vital Travel Awards 2018 – Closed

Sydney Vital invites applications for Travel Awards to the value of $1,500 for domestic travel and $3,000 for international travel. Our aim is to encourage outstanding PhD students, ECRs, researchers and clinicians from within the Sydney Vital network and institutions to present their scientific research progress at national or international conferences.

Submission Guidelines

Applications must be combined in a single PDF file and must be submitted as attachment in an email to [email protected]. Please use the following naming convention:

Last Name_ First Name_ Travel Award_ Application_2018

Last Name_ First Name_ Travel Award_ Supervisor_2018

Applications will close on Wednesday 28th February 2018. Sydney Vital Centre Manager, Suzie Nguyen, can be contacted on 9926 4726 or at [email protected] to assist with any queries.

Download guidelines here:

Sydney Vital_Travel Award_Guidelines_2018_Round 1

Read more

Sydney Vital Human Research Ethics Service

Sydney Vital members can now access our Human Research Ethics Service. Sydney Vital has employed an Ethics Coordinator, Ms Hanumasri Matturi, to assist with HREC applications. In order to access the service the project must;

  1. Have a PI who is a member of Sydney Vital
  2. Must be an Investigator Initiated Study (company sponsored studies will not be supported)
  3. Focused on cancer research

The service will be prioritised on a first come, first served basis.

For further information regarding this service please contact Sydney Vital at [email protected]

Read more

SYDNEY 2000

Development and pilot implementation of an evidence-based clinical pathway and toolkit for survivorship care in young women with breast cancer at high risk of stopping endocrine therapy prematurely (T2-T3).

Flagship Lead
Prof Boyle
Chief Investors
Prof Clarke
Prof Clarke
Prof Molloy
Prof Marsh
R. Fellow
Dr Dhillon
Dr Dhillon

Welcome to the Implementation Science Community of Practice:

The Community of Practice holds educational and networking events to support clinicians, researchers and health service managers working in implementation science. Click to jump down to:

WORKSHOPS

WEBINARS

JOURNAL CLUB MEETINGS

CONFERENCE SESSIONS

Proposal Title: Development and pilot implementation of an evidence-based clinical pathway and toolkit for survivorship care in young women with breast cancer at high risk of stopping endocrine therapy prematurely.

Read more

IMAP

NETwork (multidisciplinary management of Neureondocrine Tumors (T1-T2-T3).

 

Flagship Lead
Prof Bailey
Chief Investors
A/Prof Engel
A/Prof Nick Pavlakis
A/Prof Gill
Research Fellow
Dr David Chan

 

Project Title: Professionalising the Multidisciplinary team

Grading Neuroendocrine Tumors by Prof Bailey et al.

Read more

The Sydney 1000 Cancer Study

The Sydney 1000 Cancer Study

The role of inflammation and the immune system in cancer is being increasingly recognized. Two key questions that have not been answered are how the host innate and adaptive immune system responds to treatment, and if there is a predictive signature that could be used to inform treatment decisions.

The Sydney 1000 Cancer Study is the first study to follow 1000 patients throughout their disease and treatment trajectory while at the same time enabling the complete collection and matching of tumour and blood samples with clinical history, treatment outcomes and related changes in patient-reported quality of life. A recognised international innovation of this project is the ability to apply the Mass Cytometer-Time of Flight (CyTOF) technology to different cancers to describe the 40 different cell surface and intracellular signaling markers in a single sample. This is the only such instrument available in Australia, allowing us to identify any potential immune response signatures for the two gastrointestinal cancers, colorectal and pancreatic cancer.

With additional leveraged funding, the collection of genomic and proteomic details will be possible to complement the rich clinical and treatment data.

The first stage of this University-wide initiative, will establish the essential reporting systems and harmonised data collection across sites to support not only the proposed project, but also clinical practice and clinical trials.

Team of Investigators:

  • Dr Kellie Charles
  • Prof Stephen Clarke
  • Dr Connie Diakos
  • A/Prof Nick Pavlakis
  • Prof Alexander Engel
  • A/Prof Jas Samra
  • Prof Anthony Gill
  • A/Prof Andrew Kneebone
  • Prof Barbara Fazekas de St Groth
  • Prof Derek Hart
  • A/Prof Scott Byrne
  • Dr Helen McGuire
  • Prof Madeleine King

 

Flagship Lead
Prof Baxter
Chief Investors
Prof Clarke Prof Marsh Prof Boyle AProf Gill AProf Molloy
Prof Clarke
Prof Marsh
Prof Boyle
A/Prof Gill
A/Prof Molloy
R. Fellow
Dr Ochnik
Dr Ochnik

 

Proposal Title: Investigation of novel insulin-like growth factor (IGF)- and sphingosine kinase (SphK)-targeted therapies for ER-negative, therapy-resistant breast cancer.

Read more

SYDNEY 3000

Core Facilities links with personnel (in progress_should send out survey questionnaire to get this done- How can we help our members to promote their core facilities and how can other researchers have a better understand of how these facilities can facilitate their research activities to produce expected outcomes?)

Sydney Vital aims to make available to all members equipment, expert assistance and skills development (e.g. workshops) for preclinical research (in vitro, in vivo, tissue imaging); biobanking; clinical imaging; pathology; advanced statistics; and proteomics and genomics (inl, next-generation sequencing & bioinformatics).

A shared infrastructure platform and the skills developed activities associated with it, is what it will serve as a catalyst for interaction and knowledge-exchange between Sydney Vital members from different disciplines and sites. This in turn will encourage the cross-fertilization of ideas, leading to innovation as well as collaboration.

Read more